Document Detail


Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure.
MedLine Citation:
PMID:  1549219     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To investigate whether activation of afferent and central baroreceptor pathways could differentiate between pure autonomic failure (PAF) and multiple system atrophy with autonomic failure (MSA), we determined the effect of upright tilt on circulating levels of vasopressin in patients with PAF and patients with MSA. We also studied 14 normal subjects, nine of whom developed acute hypotension due to vasovagal syncope. In patients with PAF and in normal subjects with vasovagal syncope, upright tilt induced marked hypotension and a pronounced increase in the plasma concentration of vasopressin (1.1 +/- 0.3 to 38.0 +/- 8.0 pmol/l in PAF and 1.0 +/- 0.2 to 27.4 +/- 7.2 pmol/l in vasovagal syncope, p less than 0.005 for both). In patients with MSA, upright tilt also elicited profound hypotension but circulating levels of vasopressin increased little (0.5 +/- 0.1 to 1.5 +/- 0.3 pmol/l, p less than 0.05). During upright tilt, the plasma concentration of norepinephrine significantly increased in normal subjects but did not increase in patients with autonomic failure. Our results indicate that afferent and central baroreceptor pathways involved in vasopressin release are normal in patients with PAF but are impaired in patients with MSA. Thus, measurement of baroreceptor-mediated vasopressin release appears to provide a clear marker to differentiate between patients with PAF and patients with MSA.
Authors:
H Kaufmann; E Oribe; M Miller; P Knott; M Wiltshire-Clement; M D Yahr
Related Documents :
80219 - Supression of ventricular extrasystoles by perhexiline.
1376899 - Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold...
6507239 - Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients ...
6209319 - Comparative electrophysiologic effects of intravenous and oral procainamide in patients...
12798829 - Eligibility for biventricular pacing in patients with an implantable cardioverter defib...
2387939 - Long-term outcome in patients who survive out of hospital ventricular fibrillation and ...
21960519 - Characterization of motor patterns in isolated human colon: are there differences in pa...
7751879 - Serum levels of the soluble form of cd30 molecule as a tumor marker in cd30+ anaplastic...
80219 - Supression of ventricular extrasystoles by perhexiline.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Neurology     Volume:  42     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  1992 Mar 
Date Detail:
Created Date:  1992-04-23     Completed Date:  1992-04-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  590-3     Citation Subset:  AIM; IM    
Affiliation:
Department of Neurology, Mount Sinai School of Medicine, New York, NY.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Autonomic Nervous System Diseases / blood*,  metabolism
Female
Humans
Hypotension / blood*,  metabolism
Male
Middle Aged
Multiple Organ Failure / blood*,  metabolism
Vasopressins / blood*,  metabolism
Grant Support
ID/Acronym/Agency:
M01-RR00071/RR/NCRR NIH HHS; NS007245/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
11000-17-2/Vasopressins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low and variable presence of valproic acid in human brain.
Next Document:  Acoustic reflex abnormalities in cranial-cervical dystonia.